Graham Colditz, Professor at Washington University School of Medicine, shared a post on LinkedIn:
“After many years of research in breast cancer prevention this partnership and the Breakthrugh Device designation is a giant leap towards personalized prevention.
Supported by WashU Medicine and working with wonderful colleagues, we can advance to clinical impact and together reduce the burden of breast cancer.”
More posts featuring Breast Cancer.